A publication in the renowned scientific journal Nature describes a unique human monoclonal antibody (MPE8) discovered by the Swiss Biotech company Humabs BioMed SA in collaboration with the Institute for Research in Biomedicine (IRB) which is affiliated to the Universita della Svizzera Italiana (USI). Humabs, a privately owned spin-off company of the IRB, is focusing on the discovery of next-generation human monoclonal antibodies to treat infectious and inflammatory diseases...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/z0rMVCci9EI/265095.php
news auto sport medical
No comments:
Post a Comment